{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:27:16Z","timestamp":1792207636991,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ejca.2010.09.020","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T08:33:27Z","timestamp":1287736407000},"page":"90-97","source":"Crossref","is-referenced-by-count":89,"title":["Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group"],"prefix":"10.1016","volume":"47","author":[{"given":"Arend","family":"von Stackelberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn-Sven","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Schrauder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Henze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesche","family":"Tallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2010.09.020_b0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.seminhematol.2008.09.007","article-title":"Treatment of childhood acute lymphoblastic leukemia","volume":"46","author":"Stanulla","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejca.2010.09.020_b0150","series-title":"Treatment of acute leukemias. New directions for clinical research","first-page":"199","article-title":"Treatment of relapsed acute lymphoblastic leukemia","author":"Henze","year":"2002"},{"key":"10.1016\/j.ejca.2010.09.020_b0015","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children\u2019s Research Hospital","volume":"104","author":"Pui","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2010.09.020_b0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000215971","article-title":"Initial results of a study of the treatment of children with ALL recurrences","volume":"9","author":"Henze","year":"1986","journal-title":"Onkologie"},{"key":"10.1016\/j.ejca.2010.09.020_b0025","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V78.5.1166.bloodjournal7851166","article-title":"Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group","volume":"78","author":"Henze","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2010.09.020_b0030","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":"Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy. Results of trial ALL-REZ BFM 87","volume":"23","author":"Einsiedel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.09.020_b0035","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1182\/blood-2007-07-102525","article-title":"High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia","volume":"111","author":"Von Stackelberg","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2010.09.020_b0040","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","article-title":"Long-term outcome in children with relapsed acute lymphoblastic leukaemia after time-point and sit-of-relapse stratification and intensified short-course multidrug chemotherapy \u2013 results of trial ALL-REZ BFM 90","volume":"28","author":"Tallen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.09.020_b0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJM198110083051502","article-title":"A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission","volume":"305","author":"Johnson","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2010.09.020_b0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2008.07499.x","article-title":"Long-term outcome of initially homogeneously treated and relapsed childhood acute lymphoblastic leukaemia in Austria \u2013 a population-based report of the Austrian Berlin-Frankfurt-Muenster (BFM) Study Group","volume":"144","author":"Reismueller","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2010.09.020_b0155","first-page":"236","article-title":"Improved outcome after relapse of childhood ALL \u2013 results of trial ALL-REZ BFM 95\/96","volume":"39","author":"Von Stackelberg","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2010.09.020_b0060","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1","article-title":"Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse \u2013 the Children\u2019s Cancer Group Experience","volume":"82","author":"Gaynon","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2010.09.020_b0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2141.2000.01891.x","article-title":"The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study","volume":"108","author":"Lawson","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2010.09.020_b0160","first-page":"538","article-title":"Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemia","volume":"9","author":"Henze","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2010.09.020_b0165","first-page":"353","article-title":"Drug resistance testing as a basis for tailored therapy in children with refractory or relapsed acute lymphoblastic leukemia","author":"D\u00f6rffel","year":"1995"},{"key":"10.1016\/j.ejca.2010.09.020_b0080","unstructured":"Klumper E, Pieters R, Kaspers GJL, et al. Treatment of children with poor prognosis relapsed acute lymphoblastic leukemia based on individual drug resistance profiles: procedure. In Kaspers GJ et al., editors. Drug resistance in leukemia and lymphoma. Harwood Academic Publishers; 1993. p. 345\u201351."},{"key":"10.1016\/j.ejca.2010.09.020_b0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ejca.2010.09.020_b0090","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.1997.15.6.2231","article-title":"Philadelphia chromosome in relapsed childhood acute lymphoblastic leukaemia: a matched-pair analysis. The Berlin-Frankfurt-Munster Study Group","volume":"15","author":"Beyermann","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.09.020_b0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-2008-1046478","article-title":"IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF) \u2013 an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study","volume":"208","author":"Fleischhack","year":"1996","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.ejca.2010.09.020_b0100","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/sj.leu.2403920","article-title":"Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2010.09.020_b0105","first-page":"43","article-title":"Which children benefit from bone marrow transplant?","volume":"18","author":"Niethammer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2010.09.020_b0110","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V78.10.2780.2780","article-title":"Allogenic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the german cooperative study","volume":"78","author":"Dopfer","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2010.09.020_b0115","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1701013","article-title":"Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?","volume":"20","author":"Borgmann","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2010.09.020_b0120","first-page":"228","article-title":"Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T\/non-B ALL: results of the ALL relapse studies","volume":"18","author":"Schmid","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2010.09.020_b0125","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/jama.284.19.2469","article-title":"Understanding of prognosis among parents of children who died of cancer. Impact on treatment goals and integration of palliative care","volume":"284","author":"Wolfe","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2010.09.020_b0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2008-1065347","article-title":"Parents\u2019 perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer","volume":"220","author":"Hechler","year":"2008","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.ejca.2010.09.020_b0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/JCO.2008.17.6065","article-title":"Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group","volume":"27","author":"Bader","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.09.020_b0140","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/leu.2009.185","article-title":"Acute leukemias. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia","volume":"23","author":"Hijiya","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2010.09.020_b0145","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the children\u2019s oncology group","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804910009044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804910009044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T05:35:08Z","timestamp":1592026508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804910009044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0959804910009044"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2010.09.020","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}